KYLE KELLY: Open Payments
NPI 1457948804 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,775 in 167 payments from 21 companies in 2025. Trend: 2023 $1,454 · 2024 $2,423 · 2025 $2,775
Food & beverage: $2,770Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $300 |
| Lilly USA, LLC | 15 | $268 |
| UCB, Inc. | 12 | $261 |
| ABBVIE INC. | 16 | $258 |
| Regeneron Healthcare Solutions, Inc. | 13 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $232 |
| Incyte Corporation | 11 | $207 |
| GENZYME CORPORATION | 9 | $182 |
| E.R. Squibb & Sons, L.L.C. | 24 | $171 |
| Organon LLC | 10 | $140 |
Products named: DUPIXENT, TREMFYA, Bimzelx, OPZELURA, ILUMYA, Sotyktu, TALTZ, RINVOQ.
Industry payments across OH — which companies pay providers there.
